Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mechanistic target of rapamycin kinase complex 2 (mTORC2) is a multi-subunit protein complex that functions as a serine/threonine kinase. It is one of two distinct complexes formed by the mTOR protein, the other being mTORC1. Unlike mTORC1, mTORC2 is acutely insensitive to rapamycin and plays critical roles in regulating cell proliferation, survival, metabolism, and cytoskeletal organization.
mTORC2 inhibition (indirect, with chronic rapamycin exposure)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mechanistic Target of Rapamycin Kinase Complex 2 (mTORC2).